comparemela.com

Page 3 - Flucelvax Quadrivalent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Flucelvax Quadrivalent Approval Expanded to Include Younger Patients

The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.

FDA Approves Quadrivalent Influenza Vaccine Including Children Of Six Months

CANBERA (dpa-AFX) - Seqirus, a business of CSL Limited (CSL.AX), Friday announced that the U.S. Food and Drug Administration approved Flucelvax Quadrivalent, the company's cell-based quadrivalent

Flucelvax Quadrivalent Approval Expanded to Include Younger Patients

The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.